Medimmune Limited

Vignesh Venkatraman

Changshou Gao

Ralph Raymond Minter

Partha S Chowdhury

Charles K Stover

Bret Sellman

Reena Varkey

Nazzareno Dimasi

Sandrine Guillard

Steven Rust

Antonio Digiandomenico

Mladen Tomich

Paul Warrener

Ryan Fleming

Binyam Bezabeh

Melissa Marie Damschroder

Godfrey Rainey

Cuihua Gao

Li Peng

Ralph Minter

This disclosure relates to combination therapies comprising anti-Psl and PcrV binding molecules and related compositions, for use in prevention and treatment ofinfection.

Combination therapies using anti-pseudomonas PSL and PCRV binding molecules

This disclosure relates to polynucleotides encoding antibodies or antigen binding fragments thereof that bind toPcrV as well as vectors and host cells comprising the same.

Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv

The disclosure generally provides proteins that bind two epitopes (e.g., a first and a second epitope) and that are bivalent for binding to each of the first and second epitopes. The disclosure also provides compositions comprising such proteins, nucleic acid molecules encoding such proteins and methods of making and using such proteins.

Multispecific and multivalent binding proteins and uses thereof

Growing community of inventors

Cambridge, United Kingdom

Vignesh Venkatraman